Izumi M, Larsen P R
Metabolism. 1978 Apr;27(4):449-60. doi: 10.1016/0026-0495(78)90099-9.
Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis. In agreement with previous reports, the concentration of serum Tg was elevated in untreated hyperthyroidism due to Graves' disease, being 132 +/- 124 ng/ml (mean +/- SD) as opposed to 11 +/- 6.4 ng/ml in normal subjects. During treatment of hyperthyroidism with antithyroid drugs with or without iodide, reductions in thyroid hormone concentrations were not associated with a change in serum Tg. On the other hand, marked elevations in serum Tg to concentrations as high as 7000 ng/ml were observed within 24-48 hr after subtotal thyroidectomy or 131I treatment of patients with Graves' disease. These abrupt 10-50-fold increases in serum Tg were not associated with changes in serum T3 and T4. As previously demonstrated, patients with subacute thyroiditis may have elevated serum Tg concentrations that are not associated with elevations in serum T3 and T4. Serum Tg may remain elevated long after clinical and other biochemical mainfestations of this disease have disappeared. These data suggest that the disruption in thyroid function in patients with subacute thyroiditis may persist in a subclinical form for longer periods than previously suspected. Serum Tg appears to be a sensitive indicator of acute thyroidal damage due to surgical, radiation, or inflammatory trauma. The absence of parallel changes in serum Tg, T3, and T4 indicates that release of these thyroidal components can occur by different mechanisms and that nonthyroid tissues cannot efficiently generate T3 and T4 from circulating Tg. Accordingly, local or systemic stimulation of thyroidal Tg hydrolysis may be involved in the generation of hyperthyroidism sometimes seen in patients with subacute thyroiditis.
对因格雷夫斯病导致的甲状腺功能亢进症和亚急性甲状腺炎的部分患者血清进行检测,测量血清甲状腺球蛋白(Tg)、三碘甲状腺原氨酸(T3)和甲状腺素(T4)的浓度。与之前的报道一致,因格雷夫斯病导致的未经治疗的甲状腺功能亢进症患者血清Tg浓度升高,为132±124 ng/ml(均值±标准差),而正常受试者为11±6.4 ng/ml。在用或不用碘化物的抗甲状腺药物治疗甲状腺功能亢进症期间,甲状腺激素浓度的降低与血清Tg的变化无关。另一方面,在对格雷夫斯病患者进行甲状腺次全切除或131I治疗后的24 - 48小时内,观察到血清Tg显著升高,浓度高达7000 ng/ml。血清Tg这种突然升高10 - 50倍的情况与血清T3和T4的变化无关。如先前所示,亚急性甲状腺炎患者的血清Tg浓度可能升高,而与血清T3和T4升高无关。在该疾病的临床及其他生化表现消失后很长时间,血清Tg可能仍保持升高。这些数据表明,亚急性甲状腺炎患者甲状腺功能的破坏可能以亚临床形式持续比之前怀疑的更长时间。血清Tg似乎是手术、辐射或炎症创伤所致急性甲状腺损伤的敏感指标。血清Tg、T3和T4没有平行变化表明这些甲状腺成分的释放可能通过不同机制发生,并且非甲状腺组织不能有效地从循环中的Tg生成T3和T4。因此,甲状腺Tg水解的局部或全身刺激可能参与了亚急性甲状腺炎患者有时出现的甲状腺功能亢进症的发生。